207 related articles for article (PubMed ID: 35551175)
21. SF3A2 promotes progression and cisplatin resistance in triple-negative breast cancer via alternative splicing of MKRN1.
Deng L; Liao L; Zhang YL; Yang SY; Hu SY; Andriani L; Ling YX; Ma XY; Zhang FL; Shao ZM; Li DQ
Sci Adv; 2024 Apr; 10(14):eadj4009. PubMed ID: 38569025
[TBL] [Abstract][Full Text] [Related]
22. The clinicopathological and prognostic significances of CDC73 expression in breast cancer: A pathological and bioinformatics analysis.
E Y; Xue H; Zhang CY; Zhao MZ; Zheng HC
Histol Histopathol; 2023 Apr; 38(4):453-465. PubMed ID: 36255176
[TBL] [Abstract][Full Text] [Related]
23. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
[TBL] [Abstract][Full Text] [Related]
24. DBC2/RhoBTB2 functions as a tumor suppressor protein via Musashi-2 ubiquitination in breast cancer.
Choi YM; Kim KB; Lee JH; Chun YK; An IS; An S; Bae S
Oncogene; 2017 May; 36(20):2802-2812. PubMed ID: 27941885
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of the E3 ubiquitin ligase UBR5 and its role in skeletal muscle anabolism.
Hughes DC; Turner DC; Baehr LM; Seaborne RA; Viggars M; Jarvis JC; Gorski PP; Stewart CE; Owens DJ; Bodine SC; Sharples AP
Am J Physiol Cell Physiol; 2021 Jan; 320(1):C45-C56. PubMed ID: 33052072
[TBL] [Abstract][Full Text] [Related]
26. Transcription factor IIS cooperates with the E3 ligase UBR5 to ubiquitinate the CDK9 subunit of the positive transcription elongation factor B.
Cojocaru M; Bouchard A; Cloutier P; Cooper JJ; Varzavand K; Price DH; Coulombe B
J Biol Chem; 2011 Feb; 286(7):5012-22. PubMed ID: 21127351
[TBL] [Abstract][Full Text] [Related]
27. EglN2 contributes to triple negative breast tumorigenesis by functioning as a substrate for the FBW7 tumor suppressor.
Takada M; Zhuang M; Inuzuka H; Zhang J; Zurlo G; Zhang J; Zhang Q
Oncotarget; 2017 Jan; 8(4):6787-6795. PubMed ID: 28036276
[TBL] [Abstract][Full Text] [Related]
28. Functional significance and therapeutic implication of ring-type E3 ligases in colorectal cancer.
Liu L; Wong CC; Gong B; Yu J
Oncogene; 2018 Jan; 37(2):148-159. PubMed ID: 28925398
[TBL] [Abstract][Full Text] [Related]
29. UBR-box containing protein, UBR5, is over-expressed in human lung adenocarcinoma and is a potential therapeutic target.
Saurabh K; Shah PP; Doll MA; Siskind LJ; Beverly LJ
BMC Cancer; 2020 Aug; 20(1):824. PubMed ID: 32867711
[TBL] [Abstract][Full Text] [Related]
30. RNF144A functions as a tumor suppressor in breast cancer through ubiquitin ligase activity-dependent regulation of stability and oncogenic functions of HSPA2.
Yang YL; Zhang Y; Li DD; Zhang FL; Liu HY; Liao XH; Xie HY; Lu Q; Zhang L; Hong Q; Dong WJ; Li DQ; Shao ZM
Cell Death Differ; 2020 Mar; 27(3):1105-1118. PubMed ID: 31406303
[TBL] [Abstract][Full Text] [Related]
31. Structural insights into a HECT-type E3 ligase AREL1 and its ubiquitination activities
Singh S; Ng J; Nayak D; Sivaraman J
J Biol Chem; 2019 Dec; 294(52):19934-19949. PubMed ID: 31732561
[TBL] [Abstract][Full Text] [Related]
32. [Hydnocarpin inhibits malignant progression of triple negative breast cancer via CNOT4-mediated ubiquitination and degradation of YAP].
Ou HL; Wu H; Ren YL; Si Y; Duan ZQ; Liu XW
Zhongguo Zhong Yao Za Zhi; 2023 Aug; 48(16):4483-4492. PubMed ID: 37802875
[TBL] [Abstract][Full Text] [Related]
33. Structure of the HECT C-lobe of the UBR5 E3 ubiquitin ligase.
Matta-Camacho E; Kozlov G; Menade M; Gehring K
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Oct; 68(Pt 10):1158-63. PubMed ID: 23027739
[TBL] [Abstract][Full Text] [Related]
34. WW domain-containing E3 ubiquitin protein ligase 1 targets p63 transcription factor for ubiquitin-mediated proteasomal degradation and regulates apoptosis.
Li Y; Zhou Z; Chen C
Cell Death Differ; 2008 Dec; 15(12):1941-51. PubMed ID: 18806757
[TBL] [Abstract][Full Text] [Related]
35. Spermatid perinuclear RNA-binding protein promotes UBR5-mediated proteolysis of Dicer to accelerate triple-negative breast cancer progression.
Chen SY; Zhang FL; Zhang YL; Liao L; Deng L; Shao ZM; Liu GY; Li DQ
Cancer Lett; 2024 Apr; 586():216672. PubMed ID: 38280476
[TBL] [Abstract][Full Text] [Related]
36. UBR5 is a novel E3 ubiquitin ligase involved in skeletal muscle hypertrophy and recovery from atrophy.
Seaborne RA; Hughes DC; Turner DC; Owens DJ; Baehr LM; Gorski P; Semenova EA; Borisov OV; Larin AK; Popov DV; Generozov EV; Sutherland H; Ahmetov II; Jarvis JC; Bodine SC; Sharples AP
J Physiol; 2019 Jul; 597(14):3727-3749. PubMed ID: 31093990
[TBL] [Abstract][Full Text] [Related]
37. The E3 ubiquitin ligase UBR5 regulates centriolar satellite stability and primary cilia.
Shearer RF; Frikstad KM; McKenna J; McCloy RA; Deng N; Burgess A; Stokke T; Patzke S; Saunders DN
Mol Biol Cell; 2018 Jul; 29(13):1542-1554. PubMed ID: 29742019
[TBL] [Abstract][Full Text] [Related]
38. The role of UBR5 in tumor proliferation and oncotherapy.
Hu B; Chen S
Gene; 2024 May; 906():148258. PubMed ID: 38331119
[TBL] [Abstract][Full Text] [Related]
39. Hypoxia-induced GPCPD1 depalmitoylation triggers mitophagy via regulating PRKN-mediated ubiquitination of VDAC1.
Liu Y; Zhang H; Liu Y; Zhang S; Su P; Wang L; Li Y; Liang Y; Wang X; Zhao W; Chen B; Luo D; Zhang N; Yang Q
Autophagy; 2023 Sep; 19(9):2443-2463. PubMed ID: 36803235
[TBL] [Abstract][Full Text] [Related]
40. Hsp70 acts as a fine-switch that controls E3 ligase CHIP-mediated TAp63 and ΔNp63 ubiquitination and degradation.
Wu HH; Wang B; Armstrong SR; Abuetabh Y; Leng S; Roa WHY; Atfi A; Marchese A; Wilson B; Sergi C; Flores ER; Eisenstat DD; Leng RP
Nucleic Acids Res; 2021 Mar; 49(5):2740-2758. PubMed ID: 33619536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
